Blueberry Extract Modulates Brain Enzymes Activities and Reduces Neuroinflammation: Promising Effect on Lipopolysaccharide-Induced Depressive-Like Behavior

Neurochem Res. 2023 Mar;48(3):846-861. doi: 10.1007/s11064-022-03813-8. Epub 2022 Nov 10.

Abstract

Major depressive disorder (MDD) is one of the most common neuropsychiatric disorders with high rates of prevalence and mortality. MDD is pathophysiologically complex, and treatment options are limited. Blueberries are rich in polyphenols and have neuroprotective potential. The aim of this study was to investigate the effects of blueberry extract on neuroinflammatory and neuroplasticity parameters, as well as Na+/K+-ATPase, monoamine oxidase-A (MAO-A), and acetylcholinesterase (AChE) activities in the cerebral cortex and hippocampus of mice subject to lipopolysaccharide (LPS)-induced depressive-like behavior. We also analyzed the interaction between anthocyanins and indoleamine 2 3-dioxygenase (IDO). Male Swiss mice (60-day-old) received vehicle, fluoxetine (20 mg/kg), or blueberry extract (100 or 200 mg/kg) intragastrically for 7 days before intraperitoneal LPS (0.83 mg/kg) injection. Twenty-four hours after LPS administration, the mice were subjected to behavioral tests. Both fluoxetine and blueberry extract (200 mg/kg) decreased the immobility time in the forced swim test, without affecting locomotor activity. Fluoxetine attenuated the decrease of Na+/K+-ATPase in the cerebral cortex, while blueberry extract promoted this same effect in the hippocampus. Additionally, fluoxetine and blueberry extract attenuated the decrease in the activity of MAO-A in the hippocampus. Blueberry extract (200 mg/kg) also prevented LPS-induced increase in AChE activity in the hippocampus as well as LPS upregulation of relative mRNA expression of tumor necrosis factor alpha, interleukin (IL)-1β, and IL-10 in the cerebral cortex. Molecular docking analysis revealed binding sites for malvidin 3-galactoside (- 7.8 kcal/mol) and malvidin 3-glucoside (- 7.9 kcal/mol) residues with IDO. Taken together, these results indicate that blueberry extract improved depression-like behavior and attenuated the neurochemical and molecular changes in the brains of mice challenged with LPS.

Keywords: Anthocyanins; Depression; Inflammation; Neurotransmission.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Adenosine Triphosphatases / metabolism
  • Adenosine Triphosphatases / pharmacology
  • Animals
  • Anthocyanins / metabolism
  • Behavior, Animal
  • Brain / metabolism
  • Depression / chemically induced
  • Depression / drug therapy
  • Depression / metabolism
  • Depressive Disorder, Major* / metabolism
  • Fluoxetine / pharmacology
  • Hippocampus / metabolism
  • Lipopolysaccharides* / toxicity
  • Male
  • Mice
  • Molecular Docking Simulation
  • Monoamine Oxidase / metabolism
  • Neuroinflammatory Diseases

Substances

  • Lipopolysaccharides
  • Anthocyanins
  • Fluoxetine
  • blueberry extract
  • Acetylcholinesterase
  • Adenosine Triphosphatases
  • Monoamine Oxidase